Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RHUEPO' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 118 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vaziri, ND
      Cardiovascular effects of erythropoietin and anemia correction

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    2. Sunder-Plassmann, G; Horl, WH
      Novel aspects of erythropoietin response in renal failure patients

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    3. Voulgari, PV; Hatzimichael, EC; Tsiara, S; Tzallas, C; Drosos, AA; Bourantas, KL
      Investigation for the presence of antierythropoietin antibodies in patients with myelodysplastic syndromes

      EUROPEAN JOURNAL OF HAEMATOLOGY
    4. Stegmayr, BG; Wirell, MP
      Intravenously administered erythropoietin may cause a direct increase in blood pressure in CAPD patients

      PERITONEAL DIALYSIS INTERNATIONAL
    5. Stefanidis, I; Mertens, PR; Wurth, P; Bach, R; Makropoulos, W; Mann, H; Heintz, B
      Influence of recombinant human erythropoietin therapy on plasma endothelin-1 levels during hemodialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    6. Sifakis, S; Angelakis, E; Vardaki, E; Koumantaki, Y; Matalliotakis, I; Koumantakis, E
      Erythropoietin in the treatment of iron deficiency anemia during pregnancy

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    7. Ksiazek, A; Zaluska, WT; Ksiazek, P
      Effect of recombinant human erythropoietin on adrenergic activity in normotensive hemodialysis patients

      CLINICAL NEPHROLOGY
    8. Sunder-Plassmann, G; Horl, WH
      Novel Erythropoiesis Stimulating Protein (NESP)

      NIEREN-UND HOCHDRUCKKRANKHEITEN
    9. Kazmi, WH; Kausz, AT; Khan, S; Abichandani, R; Ruthazer, R; Obrador, GT; Pereira, BJG
      Anemia: An early complication of chronic renal insufficiency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    10. Herrera, J; Nava, M; Biol, L; Romero, F; Biol, L; Rodriguez-Iturbe, B
      Melatonin prevents oxidative stress resulting from iron and erythropoietinadministration

      AMERICAN JOURNAL OF KIDNEY DISEASES
    11. Lorenzo, JD; Rodriguez, MM; Martin, SS; Romo, JMT
      Assessment of erythropoiesis activity during hemodialysis therapy by soluble transferrin receptor levels and ferrokinetic measurements

      AMERICAN JOURNAL OF KIDNEY DISEASES
    12. Kato, A; Hamada, M; Suzuki, T; Maruyama, T; Maruyama, Y; Hishida, A
      Effect of weekly or successive iron supplementation on erythropoietin doses in patients receiving hemodialysis

      NEPHRON
    13. Seeherunvong, W; Rubio, L; Abitbol, CL; Montane, B; Strauss, J; Diaz, R; Zilleruelo, G
      Identification of poor responders to erythropoietin among children undergoing hemodialysis

      JOURNAL OF PEDIATRICS
    14. Cazzola, M
      Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin

      MEDICAL ONCOLOGY
    15. Moreau, C; Lariviere, R; Kingma, I; Grose, JH; Lebel, M
      Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    16. van Zyl-Smit, R
      Diagnosis and management of iron deficiency in chronic dialysis patients

      CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
    17. Besarab, A; Amin, N; Ahsan, M; Vogel, SE; Zazuwa, G; Frinak, S; Zazra, JJ; Anandan, JV; Gupta, A
      Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    18. Stivelman, JC
      Benefits of anaemia treatment on cognitive function

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    19. Morris, AT; Ronco, C
      Erythropoietin therapy in peritoneal dialysis patients

      PERITONEAL DIALYSIS INTERNATIONAL
    20. De Gobbi, M; Pasquero, P; Brunello, F; Paccotti, P; Mazza, U; Camaschella, C
      Juvenile hemochromatosis associated with beta-thalassemia treated by phlebotomy and recombinant human erythropoietin

      HAEMATOLOGICA
    21. Ludat, K; Paulitschke, M; Riedel, E; Hampl, H
      Complete correction of renal anemia by recombinant human erythropoietin

      CLINICAL NEPHROLOGY
    22. Kausz, AT; Obrador, GT; Pereira, BJG
      Anemia management in patients with chronic renal insufficiency

      AMERICAN JOURNAL OF KIDNEY DISEASES
    23. Dahdah, K; Patrie, JT; Bolton, WK
      Intravenous iron dextran treatment in predialysis patients with chronic renal failure

      AMERICAN JOURNAL OF KIDNEY DISEASES
    24. Collins, AJ; Ma, JZ; Ebben, J
      Impact of hematocrit on morbidity and mortality

      SEMINARS IN NEPHROLOGY
    25. Fernandez-Gallego, J; Ramos, B; Ruiz, A; Contreras, J; Bustos, GA; de Novales, EL
      Study of several factors influencing the treatment of dialysis-associated anaemia with erythropoietin

      NEFROLOGIA
    26. Breymann, C; Richter, C; Huttner, C; Huch, R; Huch, A
      Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    27. Mantovani, L; Lentini, C; Hentschel, B; Wickramanayake, PD; Loeffler, M; Diehl, V; Tesch, H
      Treatment of anaemia in myelodysplastic syndromes with prolonged administration of recombinant human granulocyte colony-stimulating factor and erythropoietin

      BRITISH JOURNAL OF HAEMATOLOGY
    28. Kuriyama, S; Tomonari, H; Hosoya, T
      Antiplatelet therapy decreases the incidence of erythropoietin-induced hypertension in predialysis patients

      CLINICAL AND EXPERIMENTAL HYPERTENSION
    29. Xia, H; Ebben, J; Ma, JZ; Collins, AJ
      Hematocrit levels and hospitalization risks in hemodialysis patients

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    30. Ma, JZ; Ebben, J; Xia, H; Collins, AJ
      Hematocrit level and associated mortality in hemodialysis patients

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    31. Cameron, JS
      Towards the millennium: a history of renal anaemia and the optimal use of epoetin

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    32. Van Damme-Lombaerts, R; Herman, J
      Erythropoietin treatment in children with renal failure

      PEDIATRIC NEPHROLOGY
    33. Nathanson, S; Deschenes, G; Bensman, A
      The biochemical and hematological assessment of iron metabolism

      ARCHIVES DE PEDIATRIE
    34. Krallis, N; Cholevas, V; Mavridis, A; Georgiou, I; Bourantas, K; Andronikou, S
      Effect of recombinant human erythropoietin in preterm infants

      EUROPEAN JOURNAL OF HAEMATOLOGY
    35. Wada, Y; Matsuoka, H; Tamai, O; Kohno, K; Okuda, S; Imaizumi, T
      Erythropoietin impairs endothelium-dependent vasorelaxation through cyclooxygenase-dependent mechanisms in humans

      AMERICAN JOURNAL OF HYPERTENSION
    36. Barth, RH
      Iron metabolism in end-stage renal disease

      SEMINARS IN DIALYSIS
    37. Kurtzman, NA; Sabatini, S
      Anemia and cardiovascular complications: Iron and EPO impact

      MINERAL AND ELECTROLYTE METABOLISM
    38. Besarab, A; Kaiser, JW; Frinak, S
      A study of parenteral iron regimens in hemodialysis patients

      AMERICAN JOURNAL OF KIDNEY DISEASES
    39. Pickett, JL; Theberge, DC; Brown, WS; Schweitzer, SU; Nissenson, AR
      Normalizing hematocrit in dialysis patients improves brain function

      AMERICAN JOURNAL OF KIDNEY DISEASES
    40. Lopez-Gomez, JM; Valderrabano, F
      Resistance to the treatment with r-H-erythropoietin

      NEFROLOGIA
    41. Berns, JS; Rudnick, MR; Cohen, RM; Bower, JD; Wood, BC
      Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease

      KIDNEY INTERNATIONAL
    42. Carlini, RG; Alonzo, EJ; Dominguez, J; Blanca, I; Weisinger, JR; Rothstein, M; Bellorin-Font, E
      Effect of recombinant human erythropoietin on endothelial cell apoptosis

      KIDNEY INTERNATIONAL
    43. Nissenson, AR; Strobos, J
      Iron deficiency in patients with renal failure

      KIDNEY INTERNATIONAL
    44. Eschbach, JW; Adamson, JW
      Iron overload in renal failure patients: Changes since the introduction oferythropoietin therapy

      KIDNEY INTERNATIONAL
    45. Muirhead, N
      Erythropoietin and renal transplantation

      KIDNEY INTERNATIONAL
    46. LEBEL M; LACASSEM S; LARIVIERE R; KINGMA I; GROSE JH
      PLASMA AND BLOOD-VESSEL ENDOTHELIN-1 CONCENTRATIONS IN HYPERTENSIVE UREMIC RATS TREATED WITH ERYTHROPOIETIN

      Clinical and experimental hypertension
    47. LEBEL M; KINGMA I; GROSE JH; LANGLOIS S
      HEMODYNAMIC AND HORMONAL CHANGES DURING ERYTHROPOIETIN THERAPY IN HEMODIALYSIS-PATIENTS

      Journal of the American Society of Nephrology
    48. BELLIZZI V; SABBATINI M; FUIANO G; SANSONE G; MAGRI P; UCCELLO F; ANDREUCCI M; DENICOLA L; CIANCIARUSO B
      THE IMPACT OF EARLY NORMALIZATION OF HEMATOCRIT BY ERYTHROPOIETIN ON RENAL DAMAGE IN THE REMNANT KIDNEY MODEL

      Nephrology, dialysis, transplantation
    49. KANG DH; YOON KI; HAN DS
      ACUTE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-LEVELS OFPROENDOTHELIN-1 AND ENDOTHELIN-1 IN HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation
    50. ROCHA JL; GENTIL MA; GILI M; GIL L; CABELLO V; BERNAL G
      CONTINUOUS INTRAVENOUS INTRADIALYSIS VERSUS INTRAVENOUS POSTDIALYSIS ERYTHROPOIETIN THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS - A RANDOMIZED, CONTROLLED, CROSSOVER STUDY

      Nephrology, dialysis, transplantation
    51. SCHAEFER RM; SCHAEFER L
      IRON MONITORING AND SUPPLEMENTATION - HOW DO WE ACHIEVE THE BEST RESULTS

      Nephrology, dialysis, transplantation
    52. RITZ E; AMANN K
      OPTIMAL HEMOGLOBIN DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN

      Nephrology, dialysis, transplantation
    53. MACDOUGALL IC
      MEETING THE CHALLENGES OF A NEW MILLENNIUM - OPTIMIZING THE USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN

      Nephrology, dialysis, transplantation
    54. TESTA M; REALI A; COPULA M; PINNA B; BIROCCHI F; PISU C; CHIAPPE F
      ROLE OF RHUEPO ON BLOOD-TRANSFUSIONS IN PRETERM INFANTS AFTER THE 15TH DAY OF LIFE

      Pediatric hematology and oncology
    55. SOHMIYA M; KAKIBA T; KATO Y
      THERAPEUTIC USE OF CONTINUOUS SUBCUTANEOUS INFUSION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MALNOURISHED PREDIALYSIS ANEMIC PATIENTS WITH DIABETIC NEPHROPATHY

      European journal of endocrinology
    56. Evers, S; Tepel, M; Obladen, M; Suhr, B; Husstedt, IW; Grotemeyer, KH; Zidek, W
      Influence of end-stage renal failure and hemodialysis on event-related potentials

      JOURNAL OF CLINICAL NEUROPHYSIOLOGY
    57. GARCIASUAREZ J; PASCUAL T; MUNOZ MA; HERRERO B; PARDO A
      MYELODYSPLASTIC SYNDROME WITH ERYTHROID HYPOPLASIA APLASIA - A CASE-REPORT AND REVIEW OF THE LITERATURE/

      American journal of hematology
    58. LEBEL M; MOREAU V; GROSE JH; KINGMA I; LANGLOIS S
      PLASMA AND PERITONEAL ENDOTHELIN LEVELS AND BLOOD-PRESSURE IN CAPD PATIENTS WITH OR WITHOUT ERYTHROPOIETIN REPLACEMENT THERAPY

      Clinical nephrology
    59. Mercuriali, F; Inghilleri, G
      Blood transfusion in oncological surgury: Role of human recombinant erythropoietin

      TUMORI
    60. SEIDEL H; SPERSCHNEIDER H
      ESTIMATION OF DIFFERENT LABORATORY PARAME TERS FOR VALUATION OF IRON-METABOLISM IN HEMODIALYSIS-PATIENTS

      Nieren- und Hochdruckkrankheiten
    61. TARNG DC; HUANG TP
      RECOMBINANT-HUMAN-ERYTHROPOIETIN RESISTANCE IN IRON-REPLETE HEMODIALYSIS-PATIENTS - ROLE OF ALUMINUM TOXICITY

      American journal of nephrology
    62. ABAD JAR; AGREDA MJ; GIL P; JAURRIETA F; RIVERO A
      LATE CUTANEOUS PSEUDOPORPHYRIA IN HEMODIA LYSIS

      Nefrologia
    63. ARROYO MVA; CASTILLA MA; BELLO E; TAN D; RIESCO A; GONZALEZPACHECO FR; CASADO S; CARAMELO C
      MECHANISMS OF PROLIFERATIVE EFFECT OF HUM AN RECOMBINANT ERYTHROPOIETIN ON ENDOTHELIAL-CELLS - ROLE OF ENDOTHELIN-1

      Nefrologia
    64. BESA EC; KUNSELMAN S; NOWELL PC
      A PILOT TRIAL OF 13-CIS-RETINOIC ACID AND ALPHA-TOCOPHEROL WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROME PATIENTS WITH PROGRESSIVE OR TRANSFUSION-DEPENDENT ANEMIAS

      Leukemia research
    65. GOICOECHEA M; MARTIN J; DESEQUERA P; QUIROGA JA; ORTIZ A; CARRENO V; CARAMELO C
      ROLE OF CYTOKINES IN THE RESPONSE TO ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS

      Kidney international
    66. FRANKE W; SCHERHAG A
      TOLERABILITY AND EFFICACY OF MULTIDOSE FORMULATIONS OF EPOETIN-BETA

      Clinical drug investigation
    67. LACASSEM S; KINGMA I; LARIVIERE R; GROSE JH; LEBEL M
      UREMIA ENHANCES THE BLOOD-PRESSURE RESPONSE TO ERYTHROPOIETIN

      Clinical and experimental hypertension
    68. NISSENSON AR
      OPTIMAL HEMATOCRIT FOR HEMODIALYSIS

      Current opinion in nephrology and hypertension
    69. CAROZZI S; NASINI MG; SANTONI O; TIROTTA A; SANNA A
      RECOMBINANT-HUMAN-ERYTHROPOIETIN RESISTANCE IN HEMODIALYSIS - EFFECTSOF PAIRED FILTRATION DIALYSIS

      ASAIO journal
    70. WALKER R
      GENERAL-MANAGEMENT OF END-STAGE RENAL-DISEASE

      BMJ. British medical journal
    71. SUNDERPLASSMANN G; SPITZAUER S; HORL WH
      THE DILEMMA OF EVALUATING IRON STATUS IN DIALYSIS PATIENTS - LIMITATIONS OF AVAILABLE DIAGNOSTIC PROCEDURES

      Nephrology, dialysis, transplantation
    72. BRAUN J; LINDNER K; SCHREIBER M; HEIDLER RA; HORL WH
      PERCENTAGE OF HYPOCHROMIC RED-BLOOD-CELLS AS PREDICTOR OF ERYTHROPOIETIC AND IRON RESPONSE AFTER IV IRON SUPPLEMENTATION IN MAINTENANCE HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation
    73. TARNG DC; HUANG TP
      UREMIC PERICARDITIS - A REVERSIBLE INFLAMMATORY STATE OF RESISTANCE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation
    74. LAWRENCE IG; PRICE DE; HOWLETT TA; HARRIS KPG; FEEHALLY J; WALLS J
      ERYTHROPOIETIN AND SEXUAL DYSFUNCTION

      Nephrology, dialysis, transplantation
    75. VALDERRABANO F
      RECOMBINANT ERYTHROPOIETIN - 10 YEARS OF CLINICAL-EXPERIENCE

      Nephrology, dialysis, transplantation
    76. NAVARRO JF; MACIA ML
      HYPOCHROMIC RED-CELLS AS AN INDICATOR OF IRON-DEFICIENCY

      Journal of rheumatology
    77. MULHERIN D; FITZGERALD O; BRESNIHAN B; ODONOGHUE D; MCCARTHY D
      HYPOCHROMIC RED-CELLS AS AN INDICATOR OF IRON-DEFICIENCY - REPLY

      Journal of rheumatology
    78. SCHMIEDER RE; LANGENFELD MRW; HILGERS KF
      ENDOGENOUS ERYTHROPOIETIN CORRELATES WITH BLOOD-PRESSURE IN ESSENTIAL-HYPERTENSION

      American journal of kidney diseases
    79. PECES R; DELATORRE M; ALCAZAR R; URRA JM
      PROSPECTIVE ANALYSIS OF THE FACTORS INFLUENCING THE ANTIBODY-RESPONSETO HEPATITIS-B VACCINE IN HEMODIALYSIS-PATIENTS

      American journal of kidney diseases
    80. PECES R; DELATORRE M; ALCAZAR R; URRA JM
      PROSPECTIVE ANALYSIS OF THE FACTORS INFLU ENCING THE ANTIBODY-RESPONSE TO HEPATITIS-B VACCINE IN HEMODIALYSIS-PATIENTS

      Nefrologia
    81. KOKOT F; WIECEK A
      EVIDENCE THAT THE ANEMIA OF RENAL-FAILURE PARTICIPATES IN OVERALL UREMIC TOXICITY

      Kidney international
    82. MUIRHEAD N
      THE CLINICAL IMPACT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN

      Journal of the Royal College of Physicians of London
    83. REISENBERGER K; EGARTER C; KAPIOTIS S; STERNBERGER B; GREGOR H; HUSSLEIN P
      TRANSFER OF ERYTHROPOIETIN ACROSS THE PLACENTA PERFUSED IN-VITRO

      Obstetrics and gynecology
    84. GOKAL R
      IS THERE A VALUE OF ERYTHROPOIETIN IN PREDIALYSIS PATIENTS

      Nephrology
    85. BEUSTERIEN KM; NISSENSON AR; PORT FK; KELLY M; STEINWALD B; WARE JE
      THE EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON FUNCTIONAL HEALTH AND WELL-BEING IN CHRONIC DIALYSIS PATIENTS

      Journal of the American Society of Nephrology
    86. BALDUS M; SALOPEK S; MOLLER M; SCHLIESSER J; KLOOKER P; REDDIG J; GANSERT U; BRASS H
      EXPERIENCE WITH ZINC PROTOPORPHYRIN AS A MARKER OF ENDOGENOUS IRON AVAILABILITY IN CHRONIC-HEMODIALYSIS PATIENTS

      Nephrology, dialysis, transplantation
    87. FRIFELT JJ; TVEDEGAARD E; BRUUN K; STEFFENSEN G; CINTIN C; BREDDAM M; DOMINGUEZ H; JORGENSEN JD
      EFFICACY OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ADMINISTERED SUBCUTANEOUSLY TO CAPD PATIENTS ONCE WEEKLY

      Peritoneal dialysis international
    88. SPIRITI MAA; LATAGLIATA R; PETTI MC
      ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROMES - DURABLE RESPONSE IN A YOUNG PATIENT

      Haematologica
    89. DORE F; BONFIGLI S; GAVIANO E; PARDINI S; LONGINOTTI M
      SERUM TRANSFERRIN RECEPTOR LEVELS IN PATIENTS WITH THALASSEMIA-INTERMEDIA DURING RHUEPO ADMINISTRATION

      Haematologica
    90. VIROT JS; JANIN G; GUILLAUMIE J; MICHEL P; DUBOT P; CHEVET D; RIFLE G
      MUST ERYTHROPOIETIN BE INJECTED BY THE SUBCUTANEOUS ROUTE FOR EVERY HEMODIALYZED PATIENT

      American journal of kidney diseases
    91. PRZYBYLSKI J; SINSKI M; KOZIAK K; LISIECKA A; WISNIEWSKI M; GACIONG Z
      ERYTHROPOIETIN-INDUCED HYPERTENSION IN THE RAT IS NOT CAUSED BY INCREASED HEMATOCRIT AND ENDOTHELIN BLOOD LEVEL

      Medical science research
    92. NISSENSON AR
      ANEMIA MANAGEMENT - CRITICAL CARE FOR THE DIALYSIS PATIENT

      Dialysis & transplantation
    93. VALDERRABANO F; MADIAS NE; SCHENA FP; CARRERA F; SILVERBERG D; KOKOT F; ZUCCHELLI P; CANNATA J; ESCHBACH JW; MALLICK NP; SELVAGGI G; TEPLAN V; EFSTRATOPOULOS AD; CHANG JM; VISWESWARAN K; HURWICH B; PAPADIMITRIOU M; LASKER N; MATHEW T
      ERYTHROPOIETIN IN CHRONIC-RENAL-FAILURE

      Kidney international
    94. ROGER SD; FLUCK RJ; MCMAHON AC; RAINE AEG
      RECOMBINANT ERYTHROPOIETIN INCREASES BLOOD-PRESSURE IN EXPERIMENTAL-HYPERTENSION AND UREMIA WITHOUT CHANGE IN VASCULAR CYTOSOLIC CALCIUM

      Nephron
    95. LUCAS MF; MARCEN R; VILLAFRUELA J; TERUEL JL; TATO A; RIVERA M; ORTUNO J
      EFFECT OF RHUEPO THERAPY IN DIALYSIS PATIENTS ON ENDOGENOUS ERYTHROPOIETIN SYNTHESIS AFTER RENAL-TRANSPLANTATION

      Nephron
    96. CARAVACA F; LOPEZMINGUEZ JR; ARROBAS M; CUBERO J; PIZARRO JL; CID MC; SANCHEZCASADO E; MIRANDA MP
      HEMODYNAMIC-CHANGES INDUCED BY THE CORRECTION OF ANEMIA BY ERYTHROPOIETIN - ROLE OF ANTIPLATELET THERAPY

      Nephrology, dialysis, transplantation
    97. TAKAHASHI S; YANAI M; OKADA K
      RECOMBINANT-HUMAN-ERYTHROPOIETIN HAS NO DIRECT OR STRONG VASOCONSTRICTOR EFFECTS IN-VIVO AND IN-VITRO

      Nephrology, dialysis, transplantation
    98. ESCHBACH JW
      THE FUTURE OF RHUEPO

      Nephrology, dialysis, transplantation
    99. ROCCA AR; MAZZAFERRO S; STIRATI G; BILANCIONI E; GIORLANDINO C
      SAFE EMPLOYMENT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PREGNANCY IN 2ANURIC PATIENTS ON REGULAR DIALYSIS TREATMENT

      Renal failure
    100. CARLSON HE; GRABER ML; GELATO MC; HERSHMAN JM
      ENDOCRINE EFFECTS OF ERYTHROPOIETIN

      International journal of artificial organs


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 10:44:38